Edition:
United States

Kaiser Aluminum Corp (KALU.OQ)

KALU.OQ on NASDAQ Stock Exchange Global Select Market

76.85USD
24 Feb 2017
Change (% chg)

-- (--)
Prev Close
$76.85
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
72,538
52-wk High
$95.65
52-wk Low
$69.51

KALU.OQ

Chart for KALU.OQ

About

Kaiser Aluminum Corporation is engaged in the production of semi-fabricated specialty aluminum products. The Company manufactures aluminum plate and sheet, and extruded and drawn products, primarily used in aerospace/high strength, automotive, general engineering and other industrial end market applications. It operates in the... (more)

Overall

Beta: 0.57
Market Cap(Mil.): $1,343.56
Shares Outstanding(Mil.): 17.48
Dividend: 0.50
Yield (%): 2.60

Financials

  KALU.OQ Industry Sector
P/E (TTM): 15.13 20.62 124.41
EPS (TTM): 5.08 -- --
ROI: 7.78 2.23 9.20
ROE: 11.61 2.85 11.58

BRIEF-Kaiser Aluminum Corp reports Q4 earnings per share $1.37

* Kaiser Aluminum Corporation reports fourth quarter and full year 2016 financial results

Feb 21 2017

BRIEF-Kaiser Aluminum announces 11 pct increase in qtrly dividend payment

* Kaiser Aluminum Corporation announces an 11 percent increase in quarterly dividend payment

Jan 17 2017

German supermarkets Edeka, Rewe agree to take over rival Kaiser's

DUESSELDORF, Germany Germany's largest supermarket group Edeka and rival Rewe on Friday agreed a deal to take over the loss-making Kaiser's chain, potentially ending years of uncertainty over the future of the group.

Dec 02 2016

BRIEF-Kaiser Aluminum Corp reports Q3 EPS of $0.82

* Kaiser Aluminum Corp reports third quarter and first nine months 2016 financial results

Oct 19 2016

Medicare EpiPen spending outpaces prescription growth: Kaiser report

NEW YORK U.S. government spending on Mylan Inc's EpiPen in the Medicare program for seniors and the disabled rose 1,151 percent from 2007 through 2014, while the number of EpiPen users grew 164 percent, the Kaiser Family Foundation said on Tuesday in an analysis.

Sep 20 2016

UPDATE 4-Senate Republicans seek probe of Mylan EpiPen oversight

NEW YORK, Sept 20 Mylan NV faced new scrutiny over price hikes for its anti-allergy EpiPen on Tuesday, with U.S. lawmakers calling for a probe of oversight of the company's rebates to government healthcare plans, while West Virginia said it was investigating whether Mylan defrauded its Medicaid department.

Sep 20 2016

Medicare EpiPen spending outpaces prescription growth -Kaiser report

NEW YORK, Sept 20 U.S. government spending on Mylan Inc's EpiPen in the Medicare program for seniors and the disabled rose 1,151 percent from 2007 through 2014, while the number of EpiPen users grew 164 percent, the Kaiser Family Foundation said on Tuesday in an analysis.

Sep 20 2016

More From Around the Web

Competitors

  Price Chg
Arconic Inc (ARNC.N) $29.32 -0.25
Arconic Inc (ARNC_p.A) $87.00 +1.50
Constellium NV (CSTM.N) $8.10 -0.20
Aleris Corp (ARS.N) -- --

Earnings vs. Estimates